GL-101

· Eirion Therapeutics Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GL-101, covering 2025-08-27 to 2025-08-27. Get the full timeline:

Most recent: Clinical Trial Update: AI-09 In Subjects With Glabellar Lines, GL-101 [Phase 1, Phase 2]